The DOI matches its Crossref record; 166 of the 166 references it cites were found in a registry or an index.
The Inflammatory Microenvironment in Hepatocellular Carcinoma: A Pivotal Role for Tumor-Associated Macrophages
Open accessAbstract
Hepatocellular carcinoma (HCC) is one of the most common and aggressive human cancers worldwide. HCC is an example of inflammation-related cancer and represents a paradigm of the relation occurring between tumor microenvironment and tumor development. Tumor-associated macrophages (TAMs) are a major component of leukocyte infiltrate of tumors and play a pivotal role in tumor progression of inflammation-related cancer, including HCC. Several studies indicate that, in the tumor microenvironment, TAMs acquire an M2-polarized phenotype and promote angiogenesis, metastasis, and suppression of adaptive immunity through the expression of cytokines, chemokines, growth factors, and matrix metalloproteases. Indeed, an established M2 macrophage population has been associated with poor prognosis in HCC. The molecular links that connect cancer cells and TAMs are not completely known, but recent studies have demonstrated that NF-κB, STAT-3, and HIF-1 signaling pathways play key roles in this crosstalk. In this paper, we discuss the current knowledge about the role of TAMs in HCC development, highlighting the role of TAM-derived cytokines, chemokines, and growth factors in the initiation and progression of liver cancer and outlining the signaling pathways involved in the interplay between cancer cells and TAMs.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Mantovani, A., Allavena, P., Sica, A., & Balkwill, F. (2008) · Nature · doi:10.1038/nature07205 · Cited by 11,399
Inflammation and cancer: back to Virchow?
Balkwill, F., & Mantovani, A. (2001) · The Lancet · doi:10.1016/s0140-6736(00)04046-0 · Cited by 7,746
Myeloid-derived-suppressor cells as regulators of the immune system
Gabrilovich, D. I., & Nagaraj, S. (2009) · Nature Reviews Immunology · doi:10.1038/nri2506 · Cited by 6,753
Cheng, A.-L., Kang, Y.-K., Chen, Z., Tsao, C.-J., Qin, S., Kim, J. S., Luo, R., Feng, J., Ye, S., Yang, T.-S., et al. (2009) · The Lancet Oncology · doi:10.1016/s1470-2045(08)70285-7 · Cited by 5,832
MANTOVANI, A., SOZZANI, S., LOCATI, M., ALLAVENA, P., & SICA, A. (2002) · Trends in Immunology · doi:10.1016/s1471-4906(02)02302-5 · Cited by 5,528
Monocyte and macrophage heterogeneity
Gordon, S., & Taylor, P. R. (2005) · Nature Reviews Immunology · doi:10.1038/nri1733 · Cited by 5,190
Macrophage Diversity Enhances Tumor Progression and Metastasis
Qian, B.-Z., & Pollard, J. W. (2010) · Cell · doi:10.1016/j.cell.2010.03.014 · Cited by 5,188
Macrophage plasticity and interaction with lymphocyte subsets: cancer as a paradigm
Biswas, S. K., & Mantovani, A. (2010) · Nature Immunology · doi:10.1038/ni.1937 · Cited by 3,840
Cellular and Molecular Immunology
Abbas, A. K., Lichtman, A. H., & Pillai, S. S. (1994) · Cited by 3,583
Nuclear factor-κB in cancer development and progression
Karin, M. (2006) · Nature · doi:10.1038/nature04870 · Cited by 3,519
Tumour-educated macrophages promote tumour progression and metastasis
Pollard, J. W. (2004) · Nature Reviews Cancer · doi:10.1038/nrc1256 · Cited by 3,367
Progenitor cell trafficking is regulated by hypoxic gradients through HIF-1 induction of SDF-1
Ceradini, D. J., Kulkarni, A. R., Callaghan, M. J., Tepper, O. M., Bastidas, N., Kleinman, M. E., Capla, J. M., Galiano, R. D., Levine, J. P., & Gurtner, G. C. (2004) · Nature Medicine · doi:10.1038/nm1075 · Cited by 2,600
The two NF-κB activation pathways and their role in innate and adaptive immunity
Bonizzi, G., & Karin, M. (2004) · Trends in Immunology · doi:10.1016/j.it.2004.03.008 · Cited by 2,535
NF-κB functions as a tumour promoter in inflammation-associated cancer
Pikarsky, E., Porat, R. M., Stein, I., Abramovitch, R., Amit, S., Kasem, S., Gutkovich-Pyest, E., Urieli-Shoval, S., Galun, E., & Ben-Neriah, Y. (2004) · Nature · doi:10.1038/nature02924 · Cited by 2,430
Distinct role of macrophages in different tumor microenvironments
Lewis, C. E., & Pollard, J. W. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-4005 · Cited by 2,225
Jonjić, S., Mutter, W., Weiland, F., Reddehase, M. J., & Koszinowski, U. H. (1989) · The Journal of experimental medicine · doi:10.1084/jem.169.4.1199 · Cited by 2,105
HIF-1α is essential for myeloid cell-mediated inflammation
Cramer, T., Yamanishi, Y., Clausen, B. E., Förster, I., Pawlinski, R., Mackman, N., Haase, V. H., Jaenisch, R., Corr, M., Nizet, V., et al. (2003) · Cell · doi:10.1016/s0092-8674(03)00154-5 · Cited by 2,046
Gender Disparity in Liver Cancer Due to Sex Differences in MyD88-Dependent IL-6 Production
Naugler, W. E., Sakurai, T., Kim, S., Maeda, S., Kim, K., Elsharkawy, A. M., & Karin, M. (2007) · Science · doi:10.1126/science.1140485 · Cited by 1,955
Crosstalk between cancer and immune cells: role of STAT3 in the tumour microenvironment
Yu, H., Kortylewski, M., & Pardoll, D. (2007) · Nature Reviews Immunology · doi:10.1038/nri1995 · Cited by 1,804
Park, E. J., Lee, J. H., Yu, G.-Y., He, G., Ali, S. R., Holzer, R. G., Österreicher, C. H., Takahashi, H., & Karin, M. (2010) · Cell · doi:10.1016/j.cell.2009.12.052 · Cited by 1,764 · cited 1×
“A better understanding of the molecular events underlining the relationship between cancer cells and TAMs may be useful for the discovery of novel therapeutic targets.”
BackgroundThe role of myeloid cells in the promotion of tumour angiogenesis
Murdoch, C., Muthana, M., Coffelt, S. B., & Lewis, C. E. (2008) · Nature Reviews Cancer · doi:10.1038/nrc2444 · Cited by 1,642
NF-κB links innate immunity to the hypoxic response through transcriptional regulation of HIF-1α
Rius, J., Guma, M., Schachtrup, C., Akassoglou, K., Zinkernagel, A. S., Nizet, V., Johnson, R. S., Haddad, G. G., & Karin, M. (2008) · Nature · doi:10.1038/nature06905 · Cited by 1,614
Macrophages, innate immunity and cancer: balance, tolerance, and diversity
Mantovani, A., & Sica, A. (2010) · Current Opinion in Immunology · doi:10.1016/j.coi.2010.01.009 · Cited by 1,484
Tumor-associated macrophages (TAM) as major players of the cancer-related inflammation
Solinas, G., Germano, G., Mantovani, A., & Allavena, P. (2009) · Journal of Leukocyte Biology · doi:10.1189/jlb.0609385 · Cited by 1,425
Fausto, N., Campbell, J. S., & Riehle, K. J. (2006) · Hepatology · doi:10.1002/hep.20969 · Cited by 1,378
NF-κB in the liver—linking injury, fibrosis and hepatocellular carcinoma
Luedde, T., & Schwabe, R. F. (2011) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2010.213 · Cited by 1,345
Manel, N., Unutmaz, D., & Littman, D. R. (2008) · Nature Immunology · doi:10.1038/ni.1610 · Cited by 1,291
Gene expression in fixed tissues and outcome in hepatocellular carcinoma
Hoshida, Y., Villanueva, A., Kobayashi, M., Peix, J., Chiang, D. Y., Camargo, A., Gupta, S., Moore, J., Wrobel, M. J., Lerner, J., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0804525 · Cited by 1,286
Movahedi, K., Laoui, D., Gysemans, C., Baeten, M., Stangé, G., Van den Bossche, J., Mack, M., Pipeleers, D., In't Veld, P., De Baetselier, P., et al. (2010) · Cancer Research · doi:10.1158/0008-5472.can-09-4672 · Cited by 1,239
Altered macrophage differentiation and immune dysfunction in tumor development
Sica, A., & Bronte, V. (2007) · Journal of Clinical Investigation · doi:10.1172/jci31422 · Cited by 1,238
NF-κB and STAT3 – key players in liver inflammation and cancer
He, G., & Karin, M. (2011) · Cell Research · doi:10.1038/cr.2010.183 · Cited by 1,197
Maeda, S., Kamata, H., Luo, J.-L., Leffert, H., & Karin, M. (2005) · Cell · doi:10.1016/j.cell.2005.04.014 · Cited by 1,164
Gao, Q., Qiu, S.-J., Fan, J., Zhou, J., Wang, X.-Y., Xiao, Y.-S., Xu, Y., Li, Y.-W., & Tang, Z.-Y. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2006.09.4565 · Cited by 1,110
Direct Visualization of Macrophage-Assisted Tumor Cell Intravasation in Mammary Tumors
Wyckoff, J. B., Wang, Y., Lin, E. Y., Li, J.-F., Goswami, S., Stanley, E. R., Segall, J. E., Pollard, J. W., & Condeelis, J. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-1823 · Cited by 1,053
Th17 and regulatory T cells in mediating and restraining inflammation
Littman, D. R., & Rudensky, A. Y. (2010) · Cell · doi:10.1016/j.cell.2010.02.021 · Cited by 1,039
Inhibiting Stat3 signaling in the hematopoietic system elicits multicomponent antitumor immunity
Kortylewski, M., Kujawski, M., Wang, T., Wei, S., Zhang, S., Pilon-Thomas, S., Niu, G., Kay, H., Mulé, J., Kerr, W. G., et al. (2005) · Nature Medicine · doi:10.1038/nm1325 · Cited by 1,031
Stout, R. D., Jiang, C., Matta, B., Tietzel, I., Watkins, S. K., & Suttles, J. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.175.1.342 · Cited by 968
A novel prognostic subtype of human hepatocellular carcinoma derived from hepatic progenitor cells
Lee, J.-S., Heo, J., Libbrecht, L., Chu, I.-S., Kaposi-Novak, P., Calvisi, D. F., Mikaelyan, A., Roberts, L. R., Demetris, A. J., Sun, Z., et al. (2006) · Nature Medicine · doi:10.1038/nm1377 · Cited by 953
Volpe, E., Servant, N., Zollinger, R., Bogiatzi, S. I., Hupé, P., Barillot, E., & Soumelis, V. (2008) · Nature Immunology · doi:10.1038/ni.1613 · Cited by 938
Murdoch, C., Giannoudis, A., & Lewis, C. E. (2004) · Blood · doi:10.1182/blood-2004-03-1109 · Cited by 915
Kuang, D.-M., Zhao, Q., Peng, C., Xu, J., Zhang, J.-P., Wu, C., & Zheng, L. (2009) · Journal of Experimental Medicine · doi:10.1084/jem.20082173 · Cited by 903
Fu, J., Xu, D., Liu, Z., Shi, M., Zhao, P., Fu, B., Zhang, Z., Yang, H., Zhang, H., Zhou, C., et al. (2007) · Gastroenterology · doi:10.1053/j.gastro.2007.03.102 · Cited by 897
Ye, Q.-H., Qin, L.-X., Forgues, M., He, P., Kim, J. W., Peng, A. C., Simon, R., Li, Y., Robles, A. I., Chen, Y., et al. (2003) · Nature Medicine · doi:10.1038/nm843 · Cited by 850
Budhu, A., Forgues, M., Ye, Q.-H., Jia, H.-L., He, P., Zanetti, K. A., Kammula, U. S., Chen, Y., Qin, L.-X., Tang, Z.-Y., et al. (2006) · Cancer Cell · doi:10.1016/j.ccr.2006.06.016 · Cited by 846
Regulation of the Chemokine Receptor CXCR4 by Hypoxia
Schioppa, T., Uranchimeg, B., Saccani, A., Biswas, S. K., Doni, A., Rapisarda, A., Bernasconi, S., Saccani, S., Nebuloni, M., Vago, L., et al. (2003) · The Journal of Experimental Medicine · doi:10.1084/jem.20030267 · Cited by 841
“Re-educating” tumor-associated macrophages by targeting NF-κB
Hagemann, T., Lawrence, T., McNeish, I., Charles, K. A., Kulbe, H., Thompson, R. G., Robinson, S. C., & Balkwill, F. R. (2008) · The Journal of Experimental Medicine · doi:10.1084/jem.20080108 · Cited by 792
Genome‐wide molecular profiles of HCV‐induced dysplasia and hepatocellular carcinoma†
Wurmbach, E., Chen, Y., Khitrov, G., Zhang, W., Roayaie, S., Schwartz, M., Fiel, I., Thung, S., Mazzaferro, V., Bruix, J., et al. (2007) · Hepatology · doi:10.1002/hep.21622 · Cited by 722
Yu, Q., & Stamenkovic, I. (1999) · Genes & Development · doi:10.1101/gad.13.1.35 · Cited by 713
Ubiquitous Activation of Ras and Jak/Stat Pathways in Human HCC
Calvisi, D. F., Ladu, S., Gorden, A., Farina, M., Conner, E. A., Lee, J., Factor, V. M., & Thorgeirsson, S. S. (2006) · Gastroenterology · doi:10.1053/j.gastro.2006.01.006 · Cited by 710
Biswas, S. K. (2006) · Blood · doi:10.1182/blood-2005-01-0428 · Cited by 696
Dual Roles of Immune Cells and Their Factors in Cancer Development and Progression
Zamarron, B. F., & Chen, W. (2011) · International Journal of Biological Sciences · doi:10.7150/ijbs.7.651 · Cited by 681
Doedens, A. L., Stockmann, C., Rubinstein, M. P., Liao, D., Zhang, N., DeNardo, D. G., Coussens, L. M., Karin, M., Goldrath, A. W., & Johnson, R. S. (2010) · Cancer Research · doi:10.1158/0008-5472.can-10-1439 · Cited by 652
Cancer related inflammation: the macrophage connection
Sica, A., Allavena, P., & Mantovani, A. (2008) · Cancer Letters · doi:10.1016/j.canlet.2008.03.028 · Cited by 601
Deletion of NEMO/IKKγ in Liver Parenchymal Cells Causes Steatohepatitis and Hepatocellular Carcinoma
Luedde, T., Beraza, N., Kotsikoris, V., van Loo, G., Nenci, A., De Vos, R., Roskams, T., Trautwein, C., & Pasparakis, M. (2007) · Cancer Cell · doi:10.1016/j.ccr.2006.12.016 · Cited by 597
Focus on hepatocellular carcinoma
Bruix, J., Boix, L., Sala, M., & Llovet, J. M. (2004) · Cancer Cell · doi:10.1016/s1535-6108(04)00058-3 · Cited by 570
Zhu, X.-D., Zhang, J.-B., Zhuang, P.-Y., Zhu, H.-G., Zhang, W., Xiong, Y.-Q., Wu, W.-Z., Wang, L., Tang, Z.-Y., & Sun, H.-C. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2007.15.6521 · Cited by 556
Guiducci, C., Vicari, A. P., Sangaletti, S., Trinchieri, G., & Colombo, M. P. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-4262 · Cited by 549
Zhang, J.-P., Yan, J., Xu, J., Pang, X.-H., Chen, M.-S., Li, L., Wu, C., Li, S.-P., & Zheng, L. (2009) · Journal of Hepatology · doi:10.1016/j.jhep.2008.12.033 · Cited by 535
Sakurai, T., He, G., Matsuzawa, A., Yu, G.-Y., Maeda, S., Hardiman, G., & Karin, M. (2008) · Cancer Cell · doi:10.1016/j.ccr.2008.06.016 · Cited by 487
Regulation of the IL-23 and IL-12 Balance by Stat3 Signaling in the Tumor Microenvironment
Kortylewski, M., Xin, H., Kujawski, M., Lee, H., Liu, Y., Harris, T., Drake, C., Pardoll, D., & Yu, H. (2009) · Cancer Cell · doi:10.1016/j.ccr.2008.12.018 · Cited by 474
Imtiyaz, H. Z., Williams, E. P., Hickey, M. M., Patel, S. A., Durham, A. C., Yuan, L.-J., Hammond, R., Gimotty, P. A., Keith, B., & Simon, M. C. (2010) · Journal of Clinical Investigation · doi:10.1172/jci39506 · Cited by 461
Saccani, A., Schioppa, T., Porta, C., Biswas, S. K., Nebuloni, M., Vago, L., Bottazzi, B., Colombo, M. P., Mantovani, A., & Sica, A. (2006) · Cancer Research · doi:10.1158/0008-5472.can-06-1867 · Cited by 455
Pietras, K., Pahler, J., Bergers, G., & Hanahan, D. (2008) · PLoS Medicine · doi:10.1371/journal.pmed.0050019 · Cited by 453
STAT1 Signaling Regulates Tumor-Associated Macrophage-Mediated T Cell Deletion
Kusmartsev, S., & Gabrilovich, D. I. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.174.8.4880 · Cited by 445
The Role of VEGF and EGFR Inhibition: Implications for Combining Anti–VEGF and Anti–EGFR Agents
Tabernero, J. (2007) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-06-0404 · Cited by 437
New vistas on macrophage differentiation and activation
Mantovani, A., Sica, A., & Locati, M. (2007) · European Journal of Immunology · doi:10.1002/eji.200636910 · Cited by 432
He, G., Yu, G.-Y., Temkin, V., Ogata, H., Kuntzen, C., Sakurai, T., Sieghart, W., Peck-Radosavljevic, M., Leffert, H. L., & Karin, M. (2010) · Cancer Cell · doi:10.1016/j.ccr.2009.12.048 · Cited by 427
Ovarian Cancer Cells Polarize Macrophages Toward A Tumor-Associated Phenotype
Hagemann, T., Wilson, J., Burke, F., Kulbe, H., Li, N. F., Plüddemann, A., Charles, K., Gordon, S., & Balkwill, F. R. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.176.8.5023 · Cited by 411
Dysregulation of growth factor signaling in human hepatocellular carcinoma
Breuhahn, K., Longerich, T., & Schirmacher, P. (2006) · Oncogene · doi:10.1038/sj.onc.1209556 · Cited by 391
Inflammation and Liver Cancer: New Molecular Links
Berasain, C., Castillo, J., Perugorria, M. J., Latasa, M. U., Prieto, J., & Avila, M. A. (2009) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2009.03704.x · Cited by 390
The tumor microenvironment in hepatocellular carcinoma: Current status and therapeutic targets
Yang, J. D., Nakamura, I., & Roberts, L. R. (2011) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2010.10.007 · Cited by 390
A Lymphotoxin-Driven Pathway to Hepatocellular Carcinoma
Haybaeck, J., Zeller, N., Wolf, M. J., Weber, A., Wagner, U., Kurrer, M. O., Bremer, J., Iezzi, G., Graf, R., Clavien, P.-A., et al. (2009) · Cancer Cell · doi:10.1016/j.ccr.2009.08.021 · Cited by 383
Wu, K., Kryczek, I., Chen, L., Zou, W., & Welling, T. H. (2009) · Cancer Research · doi:10.1158/0008-5472.can-09-0901 · Cited by 380
Zhang, W., Zhu, X.-D., Sun, H.-C., Xiong, Y.-Q., Zhuang, P.-Y., Xu, H.-X., Kong, L.-Q., Wang, L., Wu, W.-Z., & Tang, Z.-Y. (2010) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-09-2904 · Cited by 374
TGFβ-mediated upregulation of hepatic miR-181b promotes hepatocarcinogenesis by targeting TIMP3
Wang, B., Hsu, S. H., Majumder, S., Kutay, H., Huang, W., Jacob, S. T., & Ghoshal, K. (2010) · Oncogene · doi:10.1038/onc.2009.468 · Cited by 348
Schiffer, E., Housset, C., Cacheux, W., Wendum, D., Desbois‐Mouthon, C., Rey, C., Clergue, F., Poupon, R., Barbu, V., & Rosmorduc, O. (2005) · Hepatology · doi:10.1002/hep.20538 · Cited by 340
Platelet-derived growth factor C induces liver fibrosis, steatosis, and hepatocellular carcinoma
Campbell, J. S., Hughes, S. D., Gilbertson, D. G., Palmer, T. E., Holdren, M. S., Haran, A. C., Odell, M. M., Bauer, R. L., Ren, H.-P., Haugen, H. S., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0409722102 · Cited by 333
The role of cytokines in hepatocellular carcinoma
Budhu, A., & Wang, X. W. (2006) · Journal of Leukocyte Biology · doi:10.1189/jlb.0506297 · Cited by 319
Progenitor/stem cells give rise to liver cancer due to aberrant TGF-β and IL-6 signaling
Tang, Y., Kitisin, K., Jogunoori, W., Li, C., Deng, C.-X., Mueller, S. C., Ressom, H. W., Rashid, A., He, A. R., Mendelson, J. S., et al. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0705395105 · Cited by 310
Cheng, J. C.-H., Chou, C. H., Kuo, M. L., & Hsieh, C.-Y. (2006) · Oncogene · doi:10.1038/sj.onc.1209706 · Cited by 298
Chang, C., Liao, J. C., & Kuo, L. (2001) · PubMed · Cited by 294
Kuang, D.-M., Peng, C., Zhao, Q., Wu, Y., Chen, M.-S., & Zheng, L. (2010) · Hepatology · doi:10.1002/hep.23291 · Cited by 263
Cheng, A.-L., Guan, Z., Chen, Z., Tsao, C.-J., Qin, S., Kim, J. S., Yang, T.-S., Tak, W. Y., Pan, H., Yu, S., et al. (2012) · European Journal of Cancer · doi:10.1016/j.ejca.2011.12.006 · Cited by 259
Chew, V., Tow, C., Teo, M., Wong, H. L., Chan, J., Gehring, A., Loh, M., Bolze, A., Quek, R., Lee, V. K. M., et al. (2010) · Journal of Hepatology · doi:10.1016/j.jhep.2009.07.013 · Cited by 259
Leng, J., Han, C., Demetris, J. A., Michalopoulos, G. K., & Wu, T. (2003) · Hepatology · doi:10.1053/jhep.2003.50380 · Cited by 258
Tsai, C.-S., Chen, F.-H., Wang, C.-C., Huang, H.-L., Jung, S.-M., Wu, C.-J., Lee, C.-C., McBride, W. H., Chiang, C.-S., & Hong, J.-H. (2007) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2007.01.041 · Cited by 257
Zhou, J., Ding, T., Pan, W., Zhu, L., Li, L., & Zheng, L. (2009) · International Journal of Cancer · doi:10.1002/ijc.24556 · Cited by 256
Kuang, D.-M., Wu, Y., Chen, N., Cheng, J., Zhuang, S.-M., & Zheng, L. (2007) · Blood · doi:10.1182/blood-2007-01-068031 · Cited by 256
Giannelli, G., Bergamini, C., Fransvea, E., Sgarra, C., & Antonaci, S. (2005) · Gastroenterology · doi:10.1053/j.gastro.2005.09.055 · Cited by 252
Cellular and molecular pathways linking inflammation and cancer
Porta, C., Larghi, P., Rimoldi, M., Grazia Totaro, M., Allavena, P., Mantovani, A., & Sica, A. (2009) · Immunobiology · doi:10.1016/j.imbio.2009.06.014 · Cited by 250
Regulation of macrophage function in tumors: the multifaceted role of NF-κB
Hagemann, T., Biswas, S. K., Lawrence, T., Sica, A., & Lewis, C. E. (2009) · Blood · doi:10.1182/blood-2008-12-172825 · Cited by 248
Yan, W., Chang, Y., Liang, X., Cardinal, J. S., Huang, H., Thorne, S. H., Monga, S. P. S., Geller, D. A., Lotze, M. T., & Tsung, A. (2012) · Hepatology · doi:10.1002/hep.25572 · Cited by 241
Ding, T., Xu, J., Wang, F., Shi, M., Zhang, Y., Li, S.-P., & Zheng, L. (2009) · Human Pathology · doi:10.1016/j.humpath.2008.08.011 · Cited by 232
Arii, S., Mise, M., Harada, T., Furutani, M., Ishigami, S., Niwano, M., Mizumoto, M., Fukumoto, M., & Imamura, M. (1996) · Hepatology · doi:10.1002/hep.510240206 · Cited by 231
Bedossa, P., Peltier, E., Terris, B., Franco, D., & Poynard, T. (1995) · Hepatology · doi:10.1002/hep.1840210325 · Cited by 215
Shirai, Y., Kawata, S., Tamura, S., Ito, N., Tsushima, H., Takaishi, K., Kiso, S., & Matsuzawa, Y. (1994) · Cancer · doi:10.1002/1097-0142(19940501)73:9<2275::aid-cncr2820730907>3.0.co;2-t · Cited by 213
Wong, V. W., Yu, J., Cheng, A. S., Wong, G. L., Chan, H., Chu, E. S., Ng, E. K., Chan, F. K., Sung, J. J., & Chan, H. L. (2009) · International Journal of Cancer · doi:10.1002/ijc.24281 · Cited by 208
Cancer‐promoting tumor‐associated macrophages: New vistas and open questions
Mantovani, A., Germano, G., Marchesi, F., Locatelli, M., & Biswas, S. K. (2011) · European Journal of Immunology · doi:10.1002/eji.201141894 · Cited by 207
Huang, S., He, X., Ding, J., Liang, L., Zhao, Y., Zhang, Z., Yao, X., Pan, Z., Zhang, P., Li, J., et al. (2008) · International Journal of Cancer · doi:10.1002/ijc.23580 · Cited by 204
Littlepage, L. E., Sternlicht, M. D., Rougier, N., Phillips, J., Gallo, E., Yu, Y., Williams, K., Brenot, A., Gordon, J. I., & Werb, Z. (2010) · Cancer Research · doi:10.1158/0008-5472.can-09-3515 · Cited by 196
Mueller, L., Goumas, F. A., Affeldt, M., Sandtner, S., Gehling, U. M., Brilloff, S., Walter, J., Karnatz, N., Lamszus, K., Rogiers, X., et al. (2007) · The American Journal of Pathology · doi:10.2353/ajpath.2007.060661 · Cited by 190
The tumor microenvironment in hepatocellular carcinoma (Review)
Libra, M. (2012) · International Journal of Oncology · doi:10.3892/ijo.2012.1408 · Cited by 187
Ogata, H., Kobayashi, T., Chinen, T., Takaki, H., Sanada, T., Minoda, Y., Koga, K., Takaesu, G., Maehara, Y., Iida, M., et al. (2006) · Gastroenterology · doi:10.1053/j.gastro.2006.04.025 · Cited by 183
SOCS1 Is a Suppressor of Liver Fibrosis and Hepatitis-induced Carcinogenesis
Yoshida, T., Ogata, H., Kamio, M., Joo, A., Shiraishi, H., Tokunaga, Y., Sata, M., Nagai, H., & Yoshimura, A. (2004) · The Journal of Experimental Medicine · doi:10.1084/jem.20031675 · Cited by 180
Pathophysiological Role of Osteopontin in Hepatic Inflammation, Toxicity, and Cancer
Ramaiah, S. K., & Rittling, S. (2008) · Toxicological Sciences · doi:10.1093/toxsci/kfm246 · Cited by 180
Määttä, M., Soini, Y., Liakka, A., & Autio‐Harmainen, H. (2000) · PubMed · Cited by 178
An osteopontin fragment is essential for tumor cell invasion in hepatocellular carcinoma
Takafuji, V, Forgues, M., Unsworth, E., Goldsmith, P., & Wang, X. W. (2007) · Oncogene · doi:10.1038/sj.onc.1210463 · Cited by 178
Transforming Growth Factor-β1 Triggers Hepatocellular Carcinoma Invasiveness via α3β1 Integrin
Giannelli, G., Fransvea, E., Marinosci, F., Bergamini, C., Colucci, S. C., Schiraldi, O., & Antonaci, S. (2002) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)64170-3 · Cited by 176
Hepatic tumor–stroma crosstalk guides epithelial to mesenchymal transition at the tumor edge
van Zijl, F., Mair, M., Csiszar, A., Schneller, D., Zulehner, G., Huber, H., Eferl, R., Beug, H., Dolznig, H., & Mikulits, W. (2009) · Oncogene · doi:10.1038/onc.2009.253 · Cited by 175
Nakagawa, H., Maeda, S., Yoshida, H., Tateishi, R., Masuzaki, R., Ohki, T., Hayakawa, Y., Kinoshita, H., Yamakado, M., Kato, N., et al. (2009) · International Journal of Cancer · doi:10.1002/ijc.24720 · Cited by 170
Dissemination of hepatocellular carcinoma is mediated via chemokine receptor CXCR4
Schimanski, C. C., Bahre, R., Gockel, I., Müller, A., Frerichs, K., Hörner, V, Teufel, A., Simiantonaki, N., Biesterfeld, S., Wehler, T., et al. (2006) · British Journal of Cancer · doi:10.1038/sj.bjc.6603251 · Cited by 168
Werno, C., Menrad, H., Weigert, A., Dehne, N., Goerdt, S., Schledzewski, K., Kzhyshkowska, J., & Brune, B. (2010) · Carcinogenesis · doi:10.1093/carcin/bgq088 · Cited by 167
Nitric oxide, apoptosis and macrophage polarization during tumor progression
Weigert, A., & Brüne, B. (2008) · Nitric Oxide · doi:10.1016/j.niox.2008.04.021 · Cited by 163
Control of angiogenesis by the pericyte: Molecular mechanisms and significance
Hirschi, K. K., & D’Amore, P. A. `. (1997) · Experientia Supplementum · doi:10.1007/978-3-0348-9006-9_18 · Cited by 161
Regulation of liver regeneration and hepatocarcinogenesis by suppressor of cytokine signaling 3
Riehle, K. J., Campbell, J. S., McMahan, R. S., Johnson, M. M., Beyer, R. P., Bammler, T. K., & Fausto, N. (2008) · The Journal of Experimental Medicine · doi:10.1084/jem.20070820 · Cited by 161
Kuang, D., Peng, C., Zhao, Q., Wu, Y., Zhu, L., Wang, J., Yin, X., Li, L., & Zheng, L. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.0904094 · Cited by 160
Fransvea, E., Mazzocca, A., Antonaci, S., & Giannelli, G. (2008) · Hepatology · doi:10.1002/hep.22731 · Cited by 159
Ju, M., Qiu, S., Fan, J., Xiao, Y., Gao, Q., Zhou, J., Li, Y.-W., & Tang, Z. (2009) · American Journal of Clinical Pathology · doi:10.1309/ajcp86ppbngohnnl · Cited by 158
Perugorria, M. J., Latasa, M. U., Nicou, A., Cartagena‐Lirola, H., Castillo, J., Goñi, S., Vespasiani‐Gentilucci, U., Zagami, M. G., Lotersztajn, S., Prieto, J., et al. (2008) · Hepatology · doi:10.1002/hep.22437 · Cited by 151
Wu, J., Ru, N.-Y., Zhang, Y., Li, Y., Wei, D., Ren, Z., Huang, X.-F., Chen, Z.-N., & Bian, H. (2011) · Oncogene · doi:10.1038/onc.2011.149 · Cited by 147
Li, W.-C., Ye, S., Sun, R., Liu, Y., Tang, Z., Kim, Y., Karras, J. G., & Zhang, H. (2006) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-06-0484 · Cited by 146
Role of the microenvironment in hepatocellular carcinoma development and progression
Wu, S., Ma, Y., Fang, Y., Liu, L., Fu, D., & Shen, X. (2011) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2011.06.010 · Cited by 145
Sutton, A., Friand, V., Brulé, S., Chaigneau, T., Ziol, M., Sainte‐Catherine, O., Poiré, A., Saffar, L., Kraemer, M., Vassy, J., et al. (2007) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-06-0103 · Cited by 142
Elevated Plasma Osteopontin Levels in Patients with Hepatocellular Carcinoma
Kim, J., Ki, S. S., Lee, S. D., Han, C. J., Kim, Y. C., Park, S. H., Cho, S. Y., Hong, Y., Park, H. Y., Lee, M. J., et al. (2006) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2006.00679.x · Cited by 137
Mazzocca, A., Fransvea, E., Lavezzari, G., Antonaci, S., & Giannelli, G. (2009) · Hepatology · doi:10.1002/hep.23118 · Cited by 127
Yang, J., Teng, C., Wu, H., Tsai, H., Chuang, H., Tsai, T., Hsu, Y., Huang, W., Wu, L., & Su, I. (2009) · Hepatology · doi:10.1002/hep.22889 · Cited by 120
Mechanisms linking pathogens-associated inflammation and cancer
Porta, C., Riboldi, E., & Sica, A. (2011) · Cancer Letters · doi:10.1016/j.canlet.2010.10.012 · Cited by 119
Dalwadi, H., Krysan, K., Heuzé‐Vourc'h, N., Dohadwala, M., Elashoff, D. A., Sharma, S. P., Cacalano, N. A., Lichtenstein, A. K., & Dubinett, S. M. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-05-1205 · Cited by 110
Zheng, Q., Tang, Z., Xue, Q., Shi, D., Song, H.-Y., & Tang, H. (2000) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s004320000146 · Cited by 105
Shen, X., Li, N., Li, H., Zhang, T., Wang, F., & Li, Q. (2010) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-010-0833-8 · Cited by 104
Kohga, K., Tatsumi, T., Takehara, T., Tsunematsu, H., Shimizu, S., Yamamoto, M., Sasakawa, A., Miyagi, T., & Hayashi, N. (2010) · Journal of Hepatology · doi:10.1016/j.jhep.2009.12.030 · Cited by 100
Zhao, Q., Xiao, C., Wu, Y., Wei, Y., Zhu, L., Zhou, J., & Kuang, D. (2011) · European Journal of Immunology · doi:10.1002/eji.201041282 · Cited by 95
Knowles, H. J., Mole, D. R., Ratcliffe, P. J., & Harris, A. L. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-2351 · Cited by 94
Okumoto, K., Hattori, E., Tamura, K., Kiso, S., Watanabe, H., Saito, K., Saito, T., Togashi, H., & Kawata, S. (2004) · Liver International · doi:10.1111/j.1478-3231.2004.00882.x · Cited by 93
Zhang, H., Ye, Q., Ren, N., Zhao, L., Wang, Y., Wu, X., Sun, H., Wang, L., Zhang, B., Liu, Y., et al. (2006) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-006-0119-3 · Cited by 91
Inhibiting TGF-β signaling in hepatocellular carcinoma
Giannelli, G., Mazzocca, A., Fransvea, E., Lahn, M., & Antonaci, S. (2010) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2010.11.004 · Cited by 90
Cosgrove, B. D., Cheng, C., Pritchard, J. R., Stolz, D. B., Lauffenburger, D. A., & Griffith, L. G. (2008) · Hepatology · doi:10.1002/hep.22335 · Cited by 87
Benetti, A., Berenzi, A., Gambarotti, M., Garrafa, E., Gelati, M., Dessy, E., Portolani, N., Piardi, T., Giulini, S. M., Caruso, A., et al. (2008) · Cancer Research · doi:10.1158/0008-5472.can-08-1218 · Cited by 86
Ryschich, E., Lizdenis, P., Ittrich, C., Benner, A., Stahl, S. H., Hamann, A., Schmidt, J., Knolle, P. A., Arnold, B., Hämmerling, G. J., et al. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-1636 · Cited by 86
Chen, J., Li, G., Meng, H., Fan, Y., Song, Y., Wang, S., Zhu, F., Guo, C. H., Zhang, L., & Shi, Y. (2011) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-011-1094-3 · Cited by 85
Liu, H., Pan, Z., Li, A., Fu, S., Lei, Y., Sun, H., Wu, M., & Zhou, W. (2008) · Cellular and Molecular Immunology · doi:10.1038/cmi.2008.46 · Cited by 85
New molecular targets for hepatocellular carcinoma: the ErbB1 signaling system
Berasain, C., Castillo, J., Prìeto, J., & Avila, M. A. (2007) · Liver International · doi:10.1111/j.1478-3231.2006.01424.x · Cited by 80
Li, Y.-W., Qiu, S., Fan, J., Gao, Q., Zhou, J., Xiao, Y., Xu, Y., Wang, X., Sun, J., & Huang, X. (2008) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-008-0469-0 · Cited by 75
Gallucci, R. M., Simeonova, P. P., Toriumi, W., & Luster, M. I. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.164.2.872 · Cited by 73
Jia, J.-B., Wang, W., Sun, H., Zhu, X., Liu, L., Zhuang, P., Zhang, J., Zhang, W., Xu, H., Kong, L., et al. (2010) · The Oncologist · doi:10.1634/theoncologist.2009-0170 · Cited by 70
Peng, S. (2005) · World Journal of Gastroenterology · doi:10.3748/wjg.v11.i41.6521 · Cited by 66
Sakai, Y., Honda, M., Fujinaga, H., Tatsumi, I., Mizukoshi, E., Nakamoto, Y., & Kaneko, S. (2008) · Cancer Research · doi:10.1158/0008-5472.can-08-0911 · Cited by 65
Liu, F., Wang, P., Jiang, X. L., Tan, G., Qiao, H., Jiang, H., Krissansen, G. W., & Sun, X. (2008) · Cancer Science · doi:10.1111/j.1349-7006.2008.00905.x · Cited by 62
Cervello, M. (2005) · World Journal of Gastroenterology · doi:10.3748/wjg.v11.i30.4638 · Cited by 60
Wang, Y., Wang, W., Wang, L., Wang, X., & Xia, J. (2011) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2011.01337.x · Cited by 58
Mamiya, T., Yamazaki, K., Masugi, Y., Mori, T., Effendi, K., Du, W., Hibi, T., Tanabe, M., Ueda, M., Takayama, T., et al. (2010) · Laboratory Investigation · doi:10.1038/labinvest.2010.105 · Cited by 54
Arginine metabolic pathways involved in the modulation of tumor‐induced angiogenesis by macrophages
Davel, L., Jasnis, M. A., de la Torre, E., Gotoh, T., Diament, M., Magenta, G., de Lustig, E. S., & Sales, M. E. (2002) · FEBS Letters · doi:10.1016/s0014-5793(02)03682-7 · Cited by 53
Liu, Z., Yang, L., Xu, J., Zhang, X., & Wang, B. (2009) · Journal of Surgical Research · doi:10.1016/j.jss.2009.07.014 · Cited by 51
Dynamic Education of Macrophages in Different Areas of Human Tumors
Wu, Y., & Zheng, L. (2012) · Cancer Microenvironment · doi:10.1007/s12307-012-0113-z · Cited by 51
Chemokine receptor CCR6 as a prognostic factor after hepatic resection for hepatocellular carcinoma
Uchida, H., Iwashita, Y., Sasaki, A., Shibata, K., Matsumoto, T., Ohta, M., & Kitano, S. (2006) · Journal of Gastroenterology and Hepatology · doi:10.1111/j.1440-1746.2005.04157.x · Cited by 48
Takai, H., Kato, A., Kato, C., Watanabe, T., Matsubara, K., Suzuki, M., & Kataoka, H. (2009) · Liver International · doi:10.1111/j.1478-3231.2008.01968.x · Cited by 45
Roderfeld, M., Räth, T., Lammert, F., Dierkes, C., Graf, J., & Roeb, E. (2010) · World Journal of Hepatology · doi:10.4254/wjh.v2.i5.175 · Cited by 44
Fransvea, E., Mazzocca, A., Santamato, A., Azzariti, A., Antonaci, S., & Giannelli, G. (2010) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-010-1459-x · Cited by 44
XZH-5 inhibits STAT3 phosphorylation and causes apoptosis in human hepatocellular carcinoma cells
Liu, Y., Liu, A., Xu, Z., Yu, W., Wang, H., Li, C., & Lin, J. (2011) · APOPTOSIS · doi:10.1007/s10495-011-0578-0 · Cited by 36
Chen, T.-A., Wang, J.-L., Hung, S., Chu, C.-L., Cheng, Y., & Liang, S. (2011) · PLoS ONE · doi:10.1371/journal.pone.0023317 · Cited by 36
Non-parenchymal liver cells support the growth advantage in the first stages of hepatocarcinogenesis
Drucker, C., Parzefall, W., Teufelhofer, O., Grusch, M., Ellinger, A., Schulte‐Hermann, R., & Grasl‐Kraupp, B. (2005) · Carcinogenesis · doi:10.1093/carcin/bgi202 · Cited by 33
Shih, Y., Wang, M.-C., Peng, H., Chen, T.-F., Chen, L., Chang, J., & Chiu, J. (2011) · Cellular Signalling · doi:10.1016/j.cellsig.2011.11.013 · Cited by 29
Zhu, A. X., Duda, D. G., Ancukiewicz, M., di Tomaso, E., Clark, J. W., Miksad, R. A., Fuchs, C. S., Ryan, D. P., & Jain, R. K. (2010) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-10-0515 · Cited by 27
Sugai, H., Kono, K., Takahashi, A., Ichihara, F., Kawaida, H., Fujii, H., & Matsumoto, Y. (2004) · Journal of Surgical Research · doi:10.1016/j.jss.2003.10.008 · Cited by 26
Calvisi, D. F. (2011) · Hepatology · doi:10.1002/hep.24435 · Cited by 23
WeiXing, C., Tiantian, H., Qun, N., Chaohui, Y., & Xu, P. (2007) · Medical Oncology · doi:10.1007/s12032-007-0050-8 · Cited by 10
Cited by
Liver Macrophages in Tissue Homeostasis and Disease
Krenkel, O., & Tacke, F. (2017) · Nature Reviews Immunology · doi:10.1038/nri.2017.11 · Cited by 1,424
Tumour evolution in hepatocellular carcinoma
Craig, A. J., von Felden, J., Garcia-Lezana, T., Sarcognato, S., & Villanueva, A. (2020) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-019-0229-4 · Cited by 823
Obesity, Inflammation, and Cancer
Deng, T., Lyon, C. J., Bergin, S., Caligiuri, M. A., & Hsueh, W. A. (2016) · Annual Review of Pathology: Mechanisms of Disease · doi:10.1146/annurev-pathol-012615-044359 · Cited by 794
The Role of Cancer-Associated Fibroblasts and Fibrosis in Liver Cancer
Affo, S., Yu, L.-X., & Schwabe, R. F. (2017) · Annual Review of Pathology: Mechanisms of Disease · doi:10.1146/annurev-pathol-052016-100322 · Cited by 757
“A large number of proinflammatory mediators, including IL-1, IL-6, TNF-α, lymphotoxin-β, and IL-17, are upregulated in the chronically injured liver and contribute to the development of HCC (25, 56, 57).”
BackgroundLi, X., Yao, W., Yuan, Y., Chen, P., Li, B., Li, J., Chu, R., Song, H., Xie, D., Jiang, X., et al. (2017) · Gut · doi:10.1136/gutjnl-2015-310514 · Cited by 737
Metadata
- Authors
- Capece, D., Fischietti, M., Verzella, D., Gaggiano, A., Cicciarelli, G., Tessitore, A., Zazzeroni, F., & Alesse, E.
- Venue
- BioMed Research International
- Publisher
- Hindawi Limited
- Published
- 2013
- Volume
- 2013
- Pages
- 1-15
- ISSN
- 1110-7243 (ISSN-L)
- 2314-6133
- 2314-6141
- OpenAlex
- W2016828736
- Cited by
- 408
- References
- 166
- FWCI
- 9.12
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.